Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesCardiologyHealth New England CCM Prior Auth | OpenPayer
    Ask Trek AI about this page
    CurrentHealth-New-EnglandPolicy UM1006POL

    Cardiac Contractility Modulation for Heart Failure - Medical Policy

    Customize your policy alerts

    Sign up for Health-New-England Policy UM1006POL alerts

    Get alerted when Policy UM1006POL changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage and prior authorization for cardiac contractility modulation devices and related implantation, removal, repositioning, programming, and supply services. CCM is experimental and investigational for Commercial and Medicaid members; Medicare coverage follows CMS NCD 20.39.

    Policy Summary
    PayerHealth-New-England
    PolicyCardiac Contractility Modulation for Heart Failure
    Policy CodePolicy UM1006POL
    Change TypeNew Policy
    Effective DateJune 1, 2026
    Next Review DateN/A
    Key ActionSubmit clinical evidence demonstrating that the patient meets the applicable treatment, testing, or surgical procedure criteria.
    SourceLink
    POLICY UPDATE CHANGES

    A new policy establishes coverage treatment for cardiac contractility modulation by line of business.

    3Lines of business addressed
    2Non-Medicare lines with experimental and investigational status

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    1CMS Medicare coverage determination referenced
    14Procedure, device, and supply codes listed

    Coverage by Line of Business

    Commercial and Medicaid: Experimental and investigational

    For Commercial and Medicaid (BeHealthy) members:

    Commercial and Medicaid coverage stance: Health New England considers cardiac contractility modulation (CCM) experimental and investigational for these lines of business.

    The policy does not provide clinical medical-necessity criteria that would override this designation.

    Medicare: Follow CMS NCD 20.39

    For Medicare members:

    Medicare coverage standard: Coverage follows National Coverage Determination (NCD) 20.39, Cardiac Contractility Modulation (CCM) for Heart Failure (HF).NCD 20.39

    The detailed NCD criteria are not reproduced in this policy.

    CCM Procedure and Supply Codes

    Table 1. Insertion and Replacement ProceduresCPT
    0408TInsertion or replacement of permanent cardiac contractility modulation system, including contractility evaluation when performed, and programming of sensing and therapeutic parameters; pulse generator with transvenous electrodes.
    0409TInsertion or replacement of permanent cardiac contractility modulation system, including contractility evaluation when performed, and programming of sensing and therapeutic parameters; pulse generator only.
    0410TInsertion or replacement of permanent cardiac contractility modulation system, including contractility evaluation when performed, and programming of sensing and therapeutic parameters; atrial electrode only.
    0411TInsertion or replacement of permanent cardiac contractility modulation system, including contractility evaluation when performed, and programming of sensing and therapeutic parameters; ventricular electrode only.
    Table 2. Removal ProceduresCPT
    0412TRemoval of permanent cardiac contractility modulation system; pulse generator only.
    0413TRemoval of permanent cardiac contractility modulation system; transvenous electrode (atrial or ventricular).
    0414TRemoval and replacement of permanent cardiac contractility modulation system pulse generator only.
    Table 3. Repositioning ProceduresCPT
    0415TRepositioning of previously implanted cardiac contractility modulation transvenous electrode (atrial or ventricular lead).
    0416TRelocation of skin pocket for implanted cardiac contractility modulation pulse generator.
    Table 4. Programming Proceduresmixed
    0417TProgramming device evaluation (in person) with iterative adjustment of the implantable device to test the function of the device and select optimal permanent programmed values with analysis, including review and report, implantable cardiac contractility modulation system.
    0418TInterrogation device evaluation (in person) with analysis, review and report, includes connection, recording and disconnection per patient encounter, implantable cardiac contractility modulation system.
    C1824Generator, cardiac contractility modulation (implantable).
    C1898Lead, pacemaker, other than transvenous VDD single pass.
    K1030External recharging system for battery (internal) for use with implanted cardiac contractility modulation generator, replacement only.

    Authorization and Documentation Requirements

    Prior Authorization

    Prior Authorization Required for CCM Services

    Prior authorization (PA) is required for Medicare requests involving the listed CCM procedures, devices, and supplies. The listed Commercial and Medicaid items are identified as experimental and investigational (E&I) as specified below; submit requests in accordance with the member's applicable line of business and benefit requirements.

    • Insertion/replacement: 0408T, 0409T, 0410T, and 0411T require PA for Medicare; 0408T, 0409T, and 0411T are E&I for Commercial and Medicaid, while 0410T is E&I for Commercial.
    • Removal/replacement: 0412T, 0413T, and 0414T require PA for Medicare; 0412T is E&I for Commercial and Medicaid, while 0413T and 0414T are E&I for Commercial.
    • Repositioning: 0415T and 0416T require PA for Medicare; 0415T is E&I for Commercial and Medicaid, and 0416T is E&I for Commercial.
    • Programming and related devices/supplies: 0417T, 0418T, C1824, C1898, and K1030 require PA for Medicare; 0417T, 0418T, C1824, C1898, and K1030 are E&I for Commercial and Medicaid where identified by the policy. Coverage remains subject to the member's benefit plan and applicable requirements.

    Therapy Overview

    Cardiac contractility modulation (CCM) is an FDA-approved, device-based therapy for patients with heart failure. The system delivers biphasic electrical stimulation to the ventricular myocardium during the absolute refractory period to augment left ventricular contraction. The policy describes potential improvements in quality of life, New York Heart Association class, left ventricular ejection fraction, peak oxygen uptake, and the composite outcome of cardiovascular death and heart failure hospitalization.

    Cardiac Contractility Modulation

    Cardiac contractility modulation (CCM)
    Therapy typeFood and Drug Administration-approved device-based therapy for patients with heart failure
    StimulationDelivers biphasic electric stimulation to the ventricular myocardium
    TimingStimulation is delivered during the absolute refractory period
    Therapeutic effectAugments left ventricular contraction
    Policy Summary
    PayerHealth-New-England
    PolicyCardiac Contractility Modulation for Heart Failure
    Policy CodePolicy UM1006POL
    Change TypeNew Policy
    Effective DateJune 1, 2026
    Next Review DateN/A
    Key ActionSubmit clinical evidence demonstrating that the patient meets the applicable treatment, testing, or surgical procedure criteria.
    SourceLink
    On This Page
    Coverage by Line of BusinessCCM Procedure and Supply CodesAuthorization and Documentation RequirementsTherapy OverviewCardiac Contractility Modulation
    Documentation Required

    Submit Clinical Evidence

    The treating physician or primary care provider must submit clinical evidence demonstrating that the patient meets the applicable treatment, testing, or surgical-procedure criteria. Without this documentation, Health New England cannot properly review the prior authorization request.

    • Include relevant clinical documentation supporting the applicable criteria for the requested CCM service, device, or supply.
    • Clinical review criteria address medical necessity; medical necessity does not by itself guarantee coverage or payment under the member's benefit plan.
    Denial Risk

    Experimental and Investigational Status

    Health New England considers CCM experimental and investigational for all lines of business except Medicare. Requests for Commercial and Medicaid (BeHealthy) members may therefore be denied as experimental and investigational, subject to the applicable benefit plan and legal requirements.

    • Commercial: CCM is experimental and investigational.
    • Medicaid (BeHealthy): CCM is experimental and investigational.
    • Medicare is excluded from this experimental-and-investigational designation and is governed by the applicable Medicare coverage determination.
    Note

    Medicare NCD Governs

    Evaluate Medicare CCM requests under CMS National Coverage Determination (NCD) 20.39, Cardiac Contractility Modulation (CCM) for Heart Failure (HF).

    • Medicare coverage determinations must follow NCD 20.39.
    • The NCD is available through the CMS Medicare Coverage Database (MCD) Search.